Oxcarbazepine

Product NDC
90096-171
11-digit product format
900960171
Labeler code
90096
Product ID
90096-171_372b49f4-e5ec-491f-9312-38dc0c5b63c6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Oxcarbazepine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Zameer Pharmaceuticals LLC
Application
ANDA218341
Marketing category
ANDA
Marketing start
2026-07-06
Substance
OXCARBAZEPINE
Active strength
150 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218341-001OXCARBAZEPINEOXCARBAZEPINE150MGTABLET / ORALAB2026-04-29
A218341-002OXCARBAZEPINEOXCARBAZEPINE300MGTABLET / ORALAB2026-04-29
A218341-003OXCARBAZEPINEOXCARBAZEPINE600MGTABLET / ORALAB2026-04-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A218341-001AB
A218341-002AB
A218341-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A218341-001OXCARBAZEPINE150MGTABLET / ORALAB2026-04-2984e616aacf4f…
2026-09-14 22:38:342026-08A218341-002OXCARBAZEPINE300MGTABLET / ORALAB2026-04-2984e616aacf4f…
2026-09-14 22:38:342026-08A218341-003OXCARBAZEPINE600MGTABLET / ORALAB2026-04-2984e616aacf4f…
2026-08-18 06:07:402026-07A218341-001OXCARBAZEPINE150MGTABLET / ORALAB2026-04-29caaa826d4ba7…
2026-08-18 06:07:402026-07A218341-002OXCARBAZEPINE300MGTABLET / ORALAB2026-04-29caaa826d4ba7…
2026-08-18 06:07:402026-07A218341-003OXCARBAZEPINE600MGTABLET / ORALAB2026-04-29caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218341-001OXCARBAZEPINE150MGTABLET / ORALAB2026-04-29a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218341-002OXCARBAZEPINE300MGTABLET / ORALAB2026-04-29a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218341-003OXCARBAZEPINE600MGTABLET / ORALAB2026-04-29a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A218341-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A218341-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A218341-003AB184e616aacf4f…
2026-08-18 06:07:402026-07A218341-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A218341-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A218341-003AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218341-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218341-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218341-003AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Oxcarbazepine
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OXCARBAZEPINE150 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
VZI5B1W380Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
312136Internal RxNorm lookup
312137Internal RxNorm lookup
312138Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8841174a-9f4b-424f-a50d-01478f2aeb29Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OxcarbazepineOXCARBAZEPINEZameer Pharmaceuticals LLC8841174a-9f4b-424f-a50d-01478f2aeb292026-08-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218341
application number: ANDA218341
ndc (product): 90096-171
OxcarbazepineOXCARBAZEPINEUmedica Laboratories USA Inc.e46d4654-76bc-4c33-ac2b-e89ae11b76972026-05-05Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218341
application number: ANDA218341

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
90096-171-0190096017101100 TABLET, FILM COATED in 1 BOTTLE (90096-171-01) 2026-07-06NoNoCurrent